Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 206.18

+2.4%

12:52 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (19986)	5/4/1998 2:53:00 PM
From: Mudcat	Read Replies (4) of 32384

<LGND has a very broad anti-angiogenesis program that targets MMPI's among other things (also selectins). The goal is to cut off blood supply and inhibit formation of new blood vessels by blocking MMPs (matrix metalloproteins)> Lgnd, as always, is stated to have very broad programs against this diesease and that disease but the stock price never moves up. Here is a prime example that the street has absolutely no confidence in LGND. Lgnd puts out mice model data on breast cancer and the stock doesn't move. Entremed puts out mice model data and they shoot from 12 to 80. Many comments on the financial news programs state cancer related stocks are getting a boost from the Entremed news, but as ussual Lgnd is unchanged. Not good in my opinion for a company whose main thrust is supposed to be cancer. Also saw the CEO from Entremd being interviewed by Joe Kernan. Why isn't Robinson out trying similar tactics to try to earn his huge salary?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next